semaglutide swisschems Health Canada has approved the first generic injection for weight loss in Canada. The medication, called Svemia, is made by Canadian company Apotex and is the first generic version of Wegovy Novo Nordisk's semaglutide shortage officially

The company is investigating tirzepatide in patients with overweight and obesity who do not have type 2 diabetes, with Mounjaro poised to add the hot indication of chronic weight management to its label by the end of this year

The dedicated FLOW trial of subcutaneous semaglutide in T2D-related CKD showed a 24% reduction in the composite of major kidney disease events (HR 0.76, 95% CI 0.660.88) and significant reductions in cardiovascular outcomes [22], supporting GLP-1RA therapy as an evidence-based addition for cardiorenal protection in this population

Bloating or Discomfort Backed-up food and waste in the gastrointestinal tract can lead to bloating, abdominal distension, and discomfort in people experiencing constipation during Ozempic therapy

Researchers working with both peptides should maintain separate labeled vials and separate syringes

Patients with higher baseline weights experienced faster absolute weight loss